Global Checkpoint Inhibitors for Treating Cancer Market Study 2016-2026, by Segment (PD-1 inhibitors, PD-L1 inhibitors,) , by Market (Melanoma treatment, Bladder cancer treatment,) , by Company (Bristol-Myers Squibb (BMS) , Merck,)

Publisher Name :
Date: 12-Nov-2019
No. of pages: 54

Summary

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

The global Checkpoint Inhibitors for Treating Cancer market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

- PD-1 inhibitors

- PD-L1 inhibitors

- CTLA-4 inhibitors

Demand Coverage (Market Size & Forecast, Consumer Distribution):

- Melanoma treatment

- Bladder cancer treatment

- Others

Company Coverage (Sales data, Main Products & Services etc.):

- Bristol-Myers Squibb(BMS)

- Merck

- Roche

Major Region Market

- North America

- Europe

- Asia-Pacific

- South America

- Middle East & Africa

Global Checkpoint Inhibitors for Treating Cancer Market Study 2016-2026, by Segment (PD-1 inhibitors, PD-L1 inhibitors,) , by Market (Melanoma treatment, Bladder cancer treatment,) , by Company (Bristol-Myers Squibb (BMS) , Merck,)

Table of Contents

1 Industry Overview
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 Checkpoint Inhibitors for Treating Cancer Market by Type
2.1 By Type
2.1.1 PD-1 inhibitors
2.1.2 PD-L1 inhibitors
2.1.3 CTLA-4 inhibitors
2.2 Market Size by Type
2.3 Market Forecast by Type

3 Global Market Demand
3.1 Segment Overview
3.1.1 Melanoma treatment
3.1.2 Bladder cancer treatment
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast

5 Major Companies List
5.1 Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
5.2 Merck (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)

6 Conclusion

List of Tables

Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2019, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2019, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Demand 2016-2019, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Demand 2016-2019, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2026, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Demand Forecast 2020-2026, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Size & Growth 2016-2019, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Size & Growth 2016-2019, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2019, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2019, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2020-2026, by Region, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List of Figures

Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2016-2019, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2016-2019, by Type, in Volume
  • Global Circulating Tumor Cell (CTC) Diagnostics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
    Published: 12-Dec-2019        Price: US 3350 Onwards        Pages: 115
    Summary Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation. In 2018, the global Circulating Tumor Cell (CTC) Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025. This report studies the Circulating Tumor Cell (CTC) Diagnostics market size by players, regions, product ty......
  • Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
    Published: 05-Dec-2019        Price: US 1450 Onwards        Pages: 25
    This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages......
  • Emerging Cancer Diagnostic Technologies and Market Applications
    Published: 05-Dec-2019        Price: US 1850 Onwards        Pages: 110
    This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages......
  • Cancer Diagnostic Instrumentation: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers
    Published: 05-Dec-2019        Price: US 2450 Onwards        Pages: 119
    This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 119 pages......
  • Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers
    Published: 05-Dec-2019        Price: US 2450 Onwards        Pages: 185
    This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic prod......
  • Global Prostate Cancer Diagnostics Market Growth 2019-2024
    Published: 02-Dec-2019        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Prostate Cancer Diagnostics market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 14080 million by 2024, from US$ 10510 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostate Cancer Diagnostics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Prostat......
  • Global Checkpoint Inhibitors For Treating Cancer Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 116
    The Checkpoint Inhibitors For Treating Cancer market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the Checkpoint Inhibitors For Treating Cancer market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive land......
  • Global HPV Testing Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 111
    The HPV Testing market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the HPV Testing market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further......
  • Global Circulating Tumor Cells (Ctcs) Detector Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 125
    The Circulating Tumor Cells (Ctcs) Detector market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the Circulating Tumor Cells (Ctcs) Detector market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs